Cellular intrinsic factors involved in the resistance of squamous cell carcinoma to photodynamic therapy

Journal of Investigative Dermatology

Volumn 134, Issue 9, 2014, Pages 2428-2437

  Gilaberte, Yolanda ^a   Milla, Laura ^b   Salazar, Nerea ^c   Vera Alvarez, Jesús ^d   Kourani, Omar ^c   Damian, Alejandra ^c   Rivarola, Viviana ^b   Roca, Maria José ^d   Espada, Jesús ^c   González, Salvador ^e   Juarranz, Angeles ^c  

^a Hospital de San Jorge de Huesca   (Spain)

^b DEPARTAMENTO DE QUÍMICA   (Argentina)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d HOSPITAL SAN JORGE   (Spain)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; CD31 ANTIGEN; CYCLIN D1; EPIDERMAL GROWTH FACTOR; INTRINSIC FACTOR; KI 67 ANTIGEN; METHYL DELTA AMINOLEVULINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; PROTEIN CADM2; PROTEIN CCND1; PROTEIN MAP3K1; PROTEIN P53; UNCLASSIFIED DRUG; UVOMORULIN; CCND1 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; MAP3K1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; PHOTOSENSITIZING AGENT; RNA DIRECTED DNA POLYMERASE;

AGED; AMPLICON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL LINE; CANCER LOCALIZATION; CANCER RESISTANCE; CARCINOGENICITY; CELL TYPE; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE DOSAGE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CARCINOMA; TUMOR BIOPSY; TUMOR XENOGRAFT; VERY ELDERLY; WESTERN BLOTTING; ANIMAL; BIOPSY; DRUG RESISTANCE; DRUG SCREENING; METABOLISM; NEOPLASMS, SQUAMOUS CELL; NUDE MOUSE; PATHOLOGY; PHOTOCHEMOTHERAPY; PHYSIOLOGY; PROCEDURES; SKIN NEOPLASMS; TUMOR CELL LINE; TUMOR INVASION; ANIMAL CELL; CANCER CELL; NON MELANOMA SKIN CANCER; SQUAMOUS CELL CARCINOMA; XENOGRAFT;

AGED, 80 AND OVER; AMINOLEVULINIC ACID; ANIMALS; BIOPSY; CELL LINE, TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; CYCLIN D1; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MALE; MAP KINASE KINASE KINASE 1; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASMS, SQUAMOUS CELL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84906318710     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.178     Document Type: Article

References (38)

1. Agostinis P, Berg K, Cengel KA, et al. (2011). Photodynamic therapy of cancer: An update. CA Cancer J Clin 61:250-81
2. Ahmad N, Kalka K, Mukhtar H. (2001). In vitro and in vivo inhibition of epidermal growth factor receptor-Tyrosine kinase pathway by photodynamic therapy. Oncogene 20:2314-7
3. Alao JP. (2007). The regulation of cyclin D1 degradation: Roles in cancer development and the potential for therapeutic invention. Mol Cancer 6:24
4. Azimi F, Scolyer RA, Rumcheva P, et al. (2012). Tumor-infiltrating lymphocyte graDe is an independent predictor of sentinel lymph noDe status and survival in patients with cutaneous melanoma. J Clin Oncol 30:2678-83
5. Bagazgoitia L, Cuevas Santos J, Juarranz A, et al. (2011). Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers. Br J Dermatol 165:144-51
6. Barrett MT, Scheffer A, Ben-Dor A, et al. (2004). Comparative genomic hybridization using oligonucleotiDe microarrays and total genomic DNA. Proc Natl Acad Sci USA 101:17765-70
7. Bhuvaneswari R, Yuen GY, Chee SK, et al. (2011). Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model. Lasers Surg Med 43:651-62
8. Blazquez-Castro A, Carrasco E, Calvo MI, et al. (2012). Protoporphyrin IXdependent photodynamic production of endogenous ROS stimulates cell proliferation. Eur J Cell Biol 91:216-23
9. Brabender J, Danenberg KD, Metzger R, et al. (2001). Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin Cancer Res 7:1850-5
10. Calzavara-Pinton PG, Venturini M, Sala R, et al. (2008). Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Br J Dermatol 159:137-44
11. Ch'ng S, Low I, Ng D, et al. (2008). Epidermal growth factor receptor: A novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Hum Pathol 39:344-9
12. Edmonds C, Hagan S, Gallagher-Colombo SM, et al. (2012). Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3: Targeting survival pathways to increase PDT efficacy in ovarian and lung cancer. Cancer Biol Ther 13:1463-70
13. Fai D, Arpaia N, Romano I, et al. (2009). Methyl-Aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: A retrospective analysis of response in 462 patients. G Ital Dermatol Venereol 144:281-5
14. Fiechter S, Skaria A, Nievergelt H, et al. (2012). Facial basal cell carcinomas recurring after photodynamic therapy: A retrospective analysis of histological subtypes. Dermatology 224:346-51
15. Jensen V, Prasad AR, Smith A, et al. (2010). Prognostic criteria for squamous cell cancer of the skin. J Surg Res 159:509-16
16. Juarranz A, Jaen P, Sanz-Rodriguez F, et al. (2008). Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 10:148-54
17. Lan YJ, Chen H, Chen JQ, et al. (2013). Immunolocalization of vimentin, keratin 17, Ki-67, involucrin, beta-catenin and E-cadherin in cutaneous squamous cell carcinoma. Pathol Oncol Res (in press
18. Lomas A, Leonardi-Bee J, Bath-Hextall F. (2012). A systematic review of worldwiDe incidence of nonmelanoma skin cancer. Br J Dermatol 166:1069-80
19. Martinez-Carpio PA, Trelles MA. (2010). The role of epidermal growth factor receptor in photodynamic therapy: A review of the literature and proposal for future investigation. Lasers Med Sci 25:767-71
20. Medeiros LJ, Hai S, Thomazy VA, et al. (2002). Real-Time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas. Mod Pathol 15:556-64
21. Milla LN, Cogno IS, Rodriguez ME, et al. (2011). Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy. J Cell Biochem 112:2266-78
22. Morton CA, McKenna KE, Rhodes LE British Association of Dermatologists Therapy Guidelines, Audit Subcommittee, the British Photodermatology Group. (2008). Guidelines for topical photodynamic therapy: Update. Br J Dermatol 159:1245-66
23. Neville JA, Welch E, Leffell DJ. (2007). Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol 4:462-9
24. Ortiz-Policarpio B, Lui H. (2009). Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers. Skin Therapy Lett 14:1-3
25. Postiglione I, Chiaviello A, Aloj SM, et al. (2013) 5-Aminolaevulinic acid/photodynamic therapy and gefitinib in non-small cell lung cancer cell lines: A potential strategy to improve gefitinib therapeutic efficacy. Cell Prolif 46:382-95
26. Rheinwald JG, Beckett MA. (1981). Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res 41:1657-63
27. Roskoski R Jr. (2012). ERK1/2 MAP kinases: Structure, function, and regulation. Pharmacol Res 66:105-43
28. Said JW, Sassoon AF, Shintaku IP, et al. (1984). Involucrin in squamous and basal cell carcinomas of the skin: An immunohistochemical study. J Invest Dermatol 82:449-52
29. Shimizu T, Izumi H, Oga A, et al. (2001). Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology 202:203-6
30. Stebbins WG, Hanke CW. (2011). MAL-PDT for difficult to treat nonmelanoma skin cancer. Dermatol Ther 24:82-93
31. Sweeny L, Dean NR, Magnuson JS, et al. (2012). EGFR expression in advanced head and neck cutaneous squamous cell carcinoma. Head Neck 34: 681-6
32. Talmadge JE. (2011). Immune cell infiltration of primary and metastatic lesions: Mechanisms and clinical impact. Semin Cancer Biol 21:131-8
33. Toby IT, Chicoine LG, Cui H, et al. (2010). Hypoxia-induced proliferation of human pulmonary microvascular endothelial cells depends on epidermal growth factor receptor tyrosine kinase activation. Am J Physiol Lung Cell Mol Physiol 298:L600-6
34. Tong Z, Singh G, Rainbow AJ. (2002). Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Cancer Res 62:5528-35
35. Utikal J, Udart M, Leiter U, et al. (2005). Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer. Cancer Lett 219:197-204
36. Wang K, Zhang M, Qian YY, et al. (2011). Imbalanced expression of mitogenactivated protein kinase phosphatase-1 and phosphorylated extracellular signal-regulated kinases in lung squamous cell carcinoma. J Zhejiang Univ Sci B 12:828-34
37. Weyergang A, Selbo PK, Berg K. (2013). Sustained ERK [corrected] inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy. Biochim Biophys Acta 1830:2659-70
38. Zhang X, Makino T, Muchemwa FC, et al. (2007). Activation of the extracellular signal-regulated kinases signaling pathway in squamous cell carcinoma of the skin. Biosci Trends 1:156-60.